The core value assessment for innovative pharmaceutical projects is the core work of product initiation, product licensing, investment, mergers and acquisitions in pharmaceutical industry. Multi-level analysis of core values of innovative medical projects from the aspects of unmet clinical needs, market capacity, competitive landscape, clinical success rate, data, intellectual property, and the implementation capacity of R&D team can help to evaluate the commercial prospects, innovation quality and the likelihood of future success of these projects, reducing the systematic risk in new drug R&D. The strategies of core value assessment for innovative pharmaceutical projects have been introduced in this paper.

创新性医药项目核心价值评估是医药行业产品立项、产品引进、投资并购的核心工作。从未满足临床需求、市场容量、竞争格局、临 床成功率、数据、知识产权、研发团队的推进能力等多层面分析创新性医药研发项目核心价值，可以判断该项目的未来商业化前景、创新水平 和质量、未来成功实现的可能性，从而降低新药研发的系统性风险。总结和介绍了创新医药项目核心价值评估的策略。